APA (7th ed.) Citation

J, Y., S, H., D, K., HG, K., SH, K., JH, J., . . . YM, L. (2025). The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma. Archives of pharmacal research, 48(4), 351. https://doi.org/10.1007/s12272-025-01539-z

Chicago Style (17th ed.) Citation

J, You, et al. "The Inhibition of Endothelial DLL4-NOTCH1 Signaling by 2'-hydroxyflavanone Enhances Anti-PD-1 Therapy in Melanoma." Archives of Pharmacal Research 48, no. 4 (2025): 351. https://doi.org/10.1007/s12272-025-01539-z.

MLA (9th ed.) Citation

J, You, et al. "The Inhibition of Endothelial DLL4-NOTCH1 Signaling by 2'-hydroxyflavanone Enhances Anti-PD-1 Therapy in Melanoma." Archives of Pharmacal Research, vol. 48, no. 4, 2025, p. 351, https://doi.org/10.1007/s12272-025-01539-z.